Are lipid-lowering drugs also antiarrhythmic drugs?

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1998 • 5,229 citations

PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

1995 • 3,524 citations

A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias

1997 • 3,117 citations

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)

1986 • 1,758 citations

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

1994 • 1,697 citations

Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?

1986 • 1,248 citations

Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)

1993 • 637 citations

Range of serum cholesterol values in the population developing coronary artery disease

1995 • 287 citations

Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits

2001 • 251 citations

Prevention of fatal cardiac arrhythmias by polyunsaturated fatty acids

2000 • 239 citations

Antiarrhythmics Versus Implantable Defibrillators (AVID)--rationale, design, and methods.

1995 • 139 citations

Antiarrhythmics Versus Implantable Defibrillators (AVID)—Rationale, design, and methods

1995 • 134 citations

Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients

2000 • 122 citations

Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease

2001 • 100 citations

Partitioning of polyunsaturated fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes

2001 • 99 citations

Myocardial Ischemia: What Factors Determine Arrhythmogenesis?

2001 • 72 citations

Dietary fatty acids and myocardial function

1987 • 50 citations

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit

2001 • 49 citations

Some comments on ventricular afterload

1987 • 41 citations

Importance of endothelial function in mediating the benefits of lipid-lowering therapy

1998 • 29 citations

Endothelial Function and Cardiovascular Prevention: Role of Blood Lipids, Exercise, and Other Risk Factors

2001 • 26 citations

Factors related to QT interval prolongation during probucol treatment

1993 • 19 citations

Influence of dietary fat on the pharmacodynamics of propafenone in isolated, perfused rabbit hearts.

1992 • 7 citations

Influence of dietary fat on the pharmacodynamics of quinidine, procainamide and tocainide in isolated perfused rabbit hearts.

1994 • 2 citations